HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

agalsidase beta

recombinant protein for treatment of Fabry disease
Also Known As:
Fabrazyme; Genzyme brand of agalsidase beta
Networked: 75 relevant articles (12 outcomes, 21 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Germain, Dominique P: 9 articles (05/2015 - 03/2007)
2. Warnock, David G: 8 articles (05/2015 - 01/2007)
3. Linthorst, Gabor E: 7 articles (05/2015 - 01/2007)
4. Pisani, A: 7 articles (01/2013 - 03/2003)
5. Waldek, Stephen: 5 articles (05/2015 - 01/2007)
6. Desnick, Robert J: 5 articles (05/2015 - 08/2005)
7. Wanner, Christoph: 5 articles (04/2014 - 09/2003)
8. Sabbatini, M: 5 articles (01/2013 - 03/2003)
9. Spinelli, L: 5 articles (01/2013 - 08/2004)
10. Banikazemi, Maryam: 5 articles (11/2010 - 08/2005)

Related Diseases

1. Fabry Disease (Fabry's Disease)
2. Lysosomal Storage Diseases (Lysosomal Storage Disease)
3. Hypertrophy
4. Gaucher Disease (Gaucher's Disease)
5. Proteinuria

Related Drugs and Biologics

1. alpha-Galactosidase (Beano)
2. agalsidase beta
3. agalsidase alfa
4. globotriaosylceramide (globotriosylceramide)
5. Immunoglobulin G (IgG)
6. Glucosidases
7. Lysergic Acid Diethylamide (LSD)
8. imiglucerase (Cerezyme)
9. alglucerase (Ceredase)
10. Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)

Related Therapies and Procedures

1. Enzyme Replacement Therapy
2. Transplants (Transplant)
3. Aftercare (After-Treatment)
4. Intravenous Infusions
5. Transplantation (Transplant Recipients)